Her expertise spans diagnostic product development, manufacturing and operations across fields including neurology, oncology, genetics and virology. At Fujirebio, she has contributed to the development and launch of blood-based biomarker assays for neurodegenerative diseases, including Alzheimer’s disease. Throughout her career, Ina has built and scaled high-performing teams and guided organizations through growth, acquisitions and transformation. She is passionate about translating scientific discoveries into diagnostic solutions that create meaningful value for patients and healthcare systems.